Search Within

Michael Forman Berger

Formats
  1. Meeting Abstract (431)
  2. Journal Article (332)
  3. Research Letter (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Review (2)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (781)
  2. Department of Pathology and Laboratory Medicine (781)
  3. GSK Faculty (781)
  4. Human Oncology and Pathogenesis Program (781)
  5. Department of Medicine (621)
  6. Solid Tumor Oncology Division (591)

More Groups

People
  1. David Solit (319)
  2. Marc Ladanyi (220)
  3. Ahmet Zehir (191)
  4. Maria Arcila (164)
  5. Nikolaus Schultz (162)
  6. Hikmat Al-Ahmadie (110)

More People

Years
  1. 2025 (31)
  2. 2024 (47)
  3. 2023 (55)
  4. 2022 (56)
  5. 2021 (40)
  6. 2020 (47)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (67)
  3. Modern Pathology (65)
  4. Clinical Cancer Research (55)
  5. Laboratory Investigation (52)
  6. Journal of Molecular Diagnostics (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (179)
  2. American Association for Cancer Research (150)
  3. Nature Publishing Group (111)
  4. Nature Research (68)
  5. Elsevier Science, Inc. (47)
  6. Oxford University Press (41)

More Publishers

Results (781)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma
    Journal Article

    Hutchinson, K. E.; Johnson, D. B.; Johnson, A. S.; Sánchez, V.; Kuba, M.; Lu, P.; Chen, X.; Kelley, M. C.; Wang, Q.; Zhao, Z.; more...
    Oncotarget (2015)

    Fulltext@MSK | Save
  • NF1 mutations are common in desmoplastic melanoma
    Journal Article

    Wiesner, T.; Kiuru, M.; Scott, S. N.; Arcila, M.; Halpern, A. C.; Hollmann, T.; Berger, M. F.; Busam, K. J.
    American Journal of Surgical Pathology (2015)

    Fulltext@MSK | Save
  • Prospective identification of potentially actionable molecular alterations in cancers of unknown primary
    Meeting Abstract

    Varghese, A. M.; Hyman, D. M.; Zehir, A.; Vakiani, E.; Klimstra, D. S.; Ladanyi, M.; Berger, M. F.; Solit, D. B.; Saltz, L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays
    Meeting Abstract

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Molecular signature of patients with pre-treated urothelial carcinoma (UC) achieving extreme responses to pazopanib (PZP) salvage therapy
    Meeting Abstract

    Pinciroli, P.; Iyer, G.; Won, H. H.; Canevari, S.; Colecchia, M.; De Braud, F. G.; Daidone, M. G.; Giannatempo, P.; Raggi, D.; Pennati, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)
    Meeting Abstract

    Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Response to crizotinib and cabozantinib in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P. K.; Drilon, A. E.; Yu, H. A.; Krug, L. M.; Rekhtman, N.; Borsu, L.; Ginsberg, M. S.; Berger, M. F.; Ladanyi, M.; Rudin, C. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save